Great news. Whilst things have been moving slowly (and expensively) at CANN, they are continuing to create a reputation for high quality, safe products. Three quarters of submissions were rejected by the FSA. Let's now see if over the next year they demonstrate the ability to utilise the capability of Mildura to create a start to end product ready for shipping. I really look forwards to the first batch of Satipharm products grown and produced.
Great news. Whilst things have been moving slowly (and...
Add CAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.12M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CAN (ASX) Chart |
Day chart unavailable